Search Results for keywords:"hearing requests"

Found 15 results

Search Results: keywords:"hearing requests"

💰 Only
Oldest Newest
  • 2025-01767 — Importer of Controlled Substances Application: Vici Health Sciences, LLC
    Type:Notice
    Citation:90 FR 8303
    Reading Time:about a minute or two

    Vici Health Sciences, LLC has applied to become an importer of specific controlled substances to support their research and clinical trials. The Drug Enforcement Administration (DEA) is accepting public comments and objections to this application until February 27, 2025. Interested parties can submit their comments electronically through the Federal eRulemaking Portal. The DEA has specified that this permit will not authorize the import of finished medication forms for sale.

    Simple Explanation

    Vici Health Sciences wants permission to bring certain special medicines into the country for research, but you can't buy these as regular medicine. The government is listening to people's opinions on this until February 28, 2025.

  • 2024-29343 — Importer of Controlled Substances Application: Groff NA Hemplex LLC
    Type:Notice
    Citation:89 FR 101051
    Reading Time:about a minute or two

    Groff NA Hemplex LLC has applied to the Drug Enforcement Administration to become a registered importer of certain controlled substances. These substances will be imported in bulk to produce research-grade materials for clinical trial studies, specifically involving Marihuana Extract compounds. The application process allows for public comments or objections and requests for a hearing until January 13, 2025. The comments should be submitted electronically through the Federal eRulemaking Portal, while hearing requests must be directed to the DEA's office in Springfield, Virginia.

    Simple Explanation

    Groff NA Hemplex LLC wants permission to bring special plant extracts from outside the country to use for research. People can tell the government what they think about it until January 13, 2025.

  • 2025-02599 — Importer of Controlled Substances Application: Janssen Pharmaceuticals Inc.
    Type:Notice
    Citation:90 FR 9556
    Reading Time:about a minute or two

    Janssen Pharmaceuticals Inc. has filed an application with the Drug Enforcement Administration (DEA) to become an importer of certain controlled substances for analytical purposes. Public comments or objections regarding this application are accepted until March 17, 2025. Hearings can also be requested by this date. Comments should be submitted via the Federal eRulemaking Portal, and requests for hearings must be sent to the DEA at specified addresses.

    Simple Explanation

    Janssen Pharmaceuticals wants permission from the government to bring in certain special medicines to study them, and people have until March 17, 2025, to share their thoughts or ask for a meeting about it.

  • 2025-04403 — Monthly Notice; Applications and Amendments to Facility Operating Licenses and Combined Licenses Involving No Significant Hazards Considerations
    Type:Notice
    Citation:90 FR 12568
    Reading Time:about 13 minutes

    The Nuclear Regulatory Commission (NRC) published a monthly notice in accordance with the Atomic Energy Act, outlining proposed amendments to facility operating licenses and combined licenses. These amendments are considered to involve no significant hazards consideration (NSHC) and are effective immediately if determined appropriate by the NRC. Interested parties can submit comments or request hearings by the specified deadlines of April 17, 2025, and May 19, 2025, respectively. Information on obtaining documents and submitting comments is available through various methods, including the NRC's electronic systems.

    Simple Explanation

    The Nuclear Regulatory Commission wants to let people know about changes to rules at certain nuclear facilities that won't make big safety problems. They're saying people can check out these changes and tell them what they think by certain dates in April and May 2025.

  • 2025-04285 — Importer of Controlled Substance Application: Fisher Clinical Services, Inc.
    Type:Notice
    Citation:90 FR 12367
    Reading Time:about a minute or two

    Fisher Clinical Services, Inc. has applied to the Drug Enforcement Administration (DEA) to register as an importer of certain controlled substances. The company intends to import these substances solely for clinical trials. Other types of uses or commercial sales are not allowed under this registration. Interested parties can submit comments or objections electronically by April 16, 2025, and can also request a hearing on the application by the same date.

    Simple Explanation

    Fisher Clinical Services, Inc. wants permission to bring in special medicines from other countries to test them in studies. People can tell the government what they think about this by April 16, 2025, or ask to have a meeting about it.

Previous